These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 2181040

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Daily multidrug therapy for leprosy; results of a fourteen-year experience.
    de Carsalade GY, Wallach D, Spindler E, Pennec J, Cottenot F, Flageul B.
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):37-44. PubMed ID: 9207752
    [Abstract] [Full Text] [Related]

  • 3. Controlled clinical trial of two multidrug regimens with and without rifampin in highly bacilliferous BL/LL south Indian patients: a five-year report.
    Thomas A, Balakrishnan A, Nagarajan M, Prabhakar R, Tripathy SP, Christian M, Somasundaram PR.
    Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):273-80. PubMed ID: 2198314
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Risk factors for erythema nodosum leprosum.
    Manandhar R, LeMaster JW, Roche PW.
    Int J Lepr Other Mycobact Dis; 1999 Sep; 67(3):270-8. PubMed ID: 10575406
    [Abstract] [Full Text] [Related]

  • 6. A clinical trial of ethionamide and prothionamide for treatment of lepromatous leprosy.
    Fajardo TT, Guinto RS, Cellona RV, Abalos RM, Dela Cruz EC, Gelber RH.
    Am J Trop Med Hyg; 2006 Mar; 74(3):457-61. PubMed ID: 16525107
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of rhuIFN-gamma treatment in multibacillary leprosy patients.
    Sampaio EP, Malta AM, Sarno EN, Kaplan G.
    Int J Lepr Other Mycobact Dis; 1996 Sep; 64(3):268-73. PubMed ID: 8862260
    [Abstract] [Full Text] [Related]

  • 12. Relapses in multibacillary patients treated with multi-drug therapy until smear negativity: findings after twenty years.
    Norman G, Joseph G, Richard J.
    Int J Lepr Other Mycobact Dis; 2004 Mar; 72(1):1-7. PubMed ID: 15217321
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Relapses during long-term follow up with drug-susceptible M. leprae among multibacillary leprosy patients treated with multidrug therapy regimens; case reports.
    Thomas A, Hari L, Nagarajan M, Prabhakar R.
    Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):391-4. PubMed ID: 7594922
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Aplastic anaemia associated with multidrug therapy (dapsone, rifampicin and clofazimine) in a patient with lepromatous leprosy.
    Goulart IM, Reis AC, De Rezende TM, Borges AS, Ferreira MS, Nishioka SA.
    Lepr Rev; 2005 Jun; 76(2):167-9. PubMed ID: 16038251
    [No Abstract] [Full Text] [Related]

  • 18. 10-12 years follow-up of highly bacillated BL/LL leprosy patients on combined chemotherapy and immunotherapy.
    Katoch K, Katoch VM, Natrajan M, Sreevatsa, Gupta UD, Sharma VD, Shivanavar CT.
    Vaccine; 2004 Sep 09; 22(27-28):3649-57. PubMed ID: 15315844
    [Abstract] [Full Text] [Related]

  • 19. Serological monitoring of the response to chemotherapy in leprosy patients.
    Roche PW, Britton WJ, Failbus SS, Neupane KD, Theuvenet WJ.
    Int J Lepr Other Mycobact Dis; 1993 Mar 09; 61(1):35-43. PubMed ID: 8326179
    [Abstract] [Full Text] [Related]

  • 20. Experience with multidrug therapy in paucibacillary leprosy.
    Bhate RD, Gupta CM, Chattopadhyay SP, Singh IP.
    Indian J Lepr; 1986 Mar 09; 58(2):244-50. PubMed ID: 3805797
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.